- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| Mo | Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform | 64 | GlobeNewswire (Europe) | FORT MILL, S.C., June 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| Do | Catheter Precision, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 12.06. | Catheter Precision, Inc. Comments on Recent Market Activity | 79 | GlobeNewswire (Europe) | FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing... ► Artikel lesen | |
| 12.06. | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Key Progress for the LockeT Product | 4 | GlobeNewswire (USA) | ||
| 09.06. | Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital | 1 | GlobeNewswire (USA) | ||
| 09.06. | Catheter Precision gibt Aktienoptionsschein an Ladenburg Thalmann aus | 2 | Investing.com Deutsch | ||
| 06.06. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.05. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.05. | Catheter Precision Inc.: Catheter Precision, Inc. Receives CE Mark for LockeT | 1 | GlobeNewswire (USA) | ||
| 19.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Catheter Precision reports Q1 results | 3 | Seeking Alpha | ||
| 14.05. | Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | 1.096 | GlobeNewswire (Europe) | FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 13.05. | Catheter Precision raises $1.5M via private placement | 2 | Seeking Alpha | ||
| 13.05. | Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance | 5 | GlobeNewswire (USA) | ||
| 08.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Catheter Precision to acquire late-stage heart failure treatment assets in development | 1 | Seeking Alpha | ||
| 17.04. | Catheter Precision, Inc.: Catheter Precision Makes NYSE American Section 610(b) Public Announcement | 1 | GlobeNewswire (USA) | ||
| 16.04. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | Catheter Precision, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 28.03. | Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results | 296 | GlobeNewswire (Europe) | FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen |
1 2 3 Weiter >>
58 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 42,410 | -0,68 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 48,580 | +0,31 % | Aktien im Fokus: Stimmungsumschwung bei Nvidia, Analysten zurückhaltend bei FMC, De.mem erwartet Boom bei Wasseraufbereitung | ||
| ECKERT & ZIEGLER | 67,85 | -0,44 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
| BICO GROUP | 3,268 | +2,06 % | Bico Group Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| SERNOVA BIOTHERAPEUTICS | 0,100 | +3,09 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| CARDINAL HEALTH | 142,40 | -0,14 % | Cardinal Health stock hits all-time high at 166.33 USD | ||
| RESMED | 219,80 | +0,37 % | ResMed-Aktie: Kurs steigt nur geringfügig (220,1782 €) | An der US-amerikanischen Börse ist die Aktie von ResMed zur Stunde unauffällig. Der jüngste Kurs betrug 254,22 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich aktuell... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,745 | +3,33 % | Atossa Genetics Year-end 2024 slides: (Z)-endoxifen shows promise, expenses decline | ||
| UNIDOC HEALTH | 0,114 | +2,89 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
| ZIMMER BIOMET | 77,70 | +0,36 % | Dividendenbekanntmachungen (26.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AUDIUS SE DE000A40ET13 - 0,2 EUR B&M EUROPEAN VALUE RETAIL SA LU1072616219 0,097 GBP 0,1136 EUR BUILD-A-BEAR WORKSHOP INC US1200761047 0... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,240 | +1,69 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| VERU | 0,511 | +2,18 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| CYTOSORBENTS | 1,060 | -1,30 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen |
CATHETER PRECISION INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,241 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.